Cytodyn Inc (CYDY)

[DaveV-1]

The FDA does not publicly publish a list of BLA applications submitted for assessment. The FDA makes filing determinations for BLAs or they inform the applicant of the refusal to file in an official correspondence to the applicant.

Cytodyn did have a press release 8 June stating "the U.S. Food and Drug Administration (FDA) advised the Company, subject to its ongoing review, it could receive its “PDUFA date” on July 10, 2020" or the filing determination date.